TY  - CONF

T1  - EVALUATING THE COST-EFFECTIVENESS OF THE ADDITION OF RITUXIMAB TO CHEMOTHERAPY IN THE FIRST LINE TREATMENT OF FOLLICULAR LYMPHOMA PATIENTS IN THE UK

JO  - VALUE IN HEALTH

PY  - 2011/11/01

AU  - Rafia R

AU  - Papaioannou D

AU  - Stevenson M

AU  - Rathbone J

AU  - Woods HB

ED  - 

DO  - DOI: 10.1016/j.jval.2011.08.1165

VL  - 14

IS  - 7

SP  - A445

EP  - A445

Y2  - 2024/09/20

ER  -